Dr Andy Richards
Dr Andy Richards is a serial Biotechnology entrepreneur and business angel. He is currently Chairman of Altacor, Novacta and Ixico and is a director of Vectura plc, Summit Corp plc, Theradeas, Cancer Research Technology (commercial arm of CR-UK) and Babraham Bioscience Technology.
Andy is a Cambridge graduate with a PhD in Chemistry who spent his early career with ICI (now AstraZeneca) and with PA Technology. He was a founder of Chiroscience and an executive director through to the sale to Celltech in 1999. Since that time he has been founding and investing in new Cambridge based biotechnology companies including several of those listed above as well as Arakis, Geneservice, Cambridge Biotechnology Ltd, Amedis Pharmaceuticals, Sirus Pharmaceuticals, Daniolabs and Pharmakodex, all of which were recently sold.
He is a council member of the Biotechnology and Biological Sciences Research Council (BBSRC), a founder member of the Cambridge Angels, the founding Chairman of BIA Bioangels and an advisor to CUTEC, 4D-biomedical and Toscana Life Sciences.
Andy is a Cambridge graduate with a PhD in Chemistry who spent his early career with ICI (now AstraZeneca) and with PA Technology. He was a founder of Chiroscience and an executive director through to the sale to Celltech in 1999. Since that time he has been founding and investing in new Cambridge based biotechnology companies including several of those listed above as well as Arakis, Geneservice, Cambridge Biotechnology Ltd, Amedis Pharmaceuticals, Sirus Pharmaceuticals, Daniolabs and Pharmakodex, all of which were recently sold.
He is a council member of the Biotechnology and Biological Sciences Research Council (BBSRC), a founder member of the Cambridge Angels, the founding Chairman of BIA Bioangels and an advisor to CUTEC, 4D-biomedical and Toscana Life Sciences.
search this section
